leisure time -WSS

leisure time

author：entertainment 2025-09-30 00:09:31 - browse：48

President Biden speaks on the Cancer Moonshot initiative at the John F. Kennedy Library in 2022. Evan Vucci/AP

WASHINGTON — The next chapter of President Biden’s moonshot to end cancer has landed. While the new goals are inspiring hope among cancer researchers, not everyone is impressed.

The president early Wednesday morning unveiled a slew of federal plans and private-sector agreements to fuel the relaunched Cancer Moonshot, a project to improve treatments and halve cancer deaths in the next 25 years. Among roughly 50 new programs and partnerships are multimillion-dollar pledges to advance testing, data pools, clinical trials and outreach efforts.

It is the latest phase of a project Biden first launched as vice president in the wake of his son Beau’s death from brain cancer in 2015. But while the first moonshot funneled money almost entirely to early-stage cancer research, its sequel is broadening efforts to prevent cancer deaths — particularly through anti-smoking efforts — and introduces a new focus on research infrastructure and patient engagement that some cancer researchers have applauded.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Kale crackers and hibiscus tea: My five days on a 'fasting diet'

WSS

ALS advocates say criticism of new drugs misses bigger picture

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Ethical issues complicate the benefits of medical crowdfunding

ALS advocates say criticism of new drugs misses bigger picture

Biotech companies concerned about China biosecurity crackdown

In search for therapies for solid tumors, companies turn to claudin

explore

leisure time

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

NIH nominee Bertagnolli will get October confirmation hearing

After affirmative action ruling, medical educators look to 'holistic review'

Humana sues Biden admin over Medicare Advantage audit rule

ChatGPT in medicine: STAT answers readers' burning questions

Medical device lobby: We're tired of waiting on Medicare coverage

Hepatitis C has a cure — but many Americans still lack access to it

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Walensky prepares to leave CDC — and Congress — behind

Medical device lobby: We're tired of waiting on Medicare coverage

focus

Humana sues Biden admin over Medicare Advantage audit rule

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Weighted lottery helped low

FDA does about

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

hotspot

hotspot

hotspot

focus